MoonLake Immunotherapeutics AG

Clinical research in hidradenitis suppurativa focuses on moderate-to-severe disease, with attention to both symptom control and longer-term safety and tolerability outcomes.

• Inflammatory skin disease
• Moderate-to-severe hidradenitis suppurativa
• Long-term safety

Trials in this area reflect interest in persistent cutaneous inflammation and treatment response over extended follow-up.